A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer

ABSTRACT: The pilot study is designed to investigate the value of Neo-adjuvant Tomudez in combination with radiotherapy in patients with inoperable or recurrent rectal cancer in terms of response rate and increasing the resectability of initially inoperable rectal cancer.

DISEASE(S): Inoperable Or Recurrent Rectal Cancer,Rectal Neoplasms

PROVIDER: 2048769 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR